Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment

doi:10.5501/wjv.v11.i5.275

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3027)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

184

WORD

HTML

1730

Figures (1-1)

314

Sum=2260

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

288

Download

479

Sum=767

Sep 25, 2022 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virol. Sep 25, 2022; 11(5): 275-282
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.275

Full Size Figure Download Figure

Figure 1 Algorithm of hepatitis B virus reactivation diagnosis and management in patients eligible for immunosuppressant in non-oncological setting. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen.

Citation: Spera AM. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment. World J Virol 2022; 11(5): 275-282
URL: https://www.wjgnet.com/2220-3249/full/v11/i5/275.htm
DOI: https://dx.doi.org/10.5501/wjv.v11.i5.275